Skip to main content
Top
Published in: Obesity Surgery 5/2011

01-05-2011 | Physiology Research

Gastric Emptying and Postprandial PYY Response After Biliopancreatic Diversion with Duodenal Switch

Authors: Jakob Hedberg, Hans Hedenström, F. Anders Karlsson, Britt Edén-Engström, Magnus Sundbom

Published in: Obesity Surgery | Issue 5/2011

Login to get access

Abstract

Background

Super-obesity (BMI > 50) is increasing rapidly. We use the biliopancreatic diversion with duodenal switch (BPD-DS) as one option in this patient category. The aim of the present study was to investigate the emptying of the gastric tube, PYY levels and dumping symptoms after BPD-DS.

Methods

Emptying of the gastric tube was investigated with scintigraphy after an overnight fast. Twenty patients (median age 43 years, BMI 31.1 kg/m2) having undergone BPD-DS in median 3.5 years previously were included in the scintigraphic study. A technetium-labelled omelette was ingested and scintigraphic evaluation of gastric emptying was undertaken. Ten of the patients also underwent PYY measurements after a standardised meal and were compared to nine non-operated age-matched normal weight controls, both in the fasting state and after the test meal. Frequency of dumping symptoms was evaluated in all patients.

Results

The half-emptying time was 28 ± 16 min. Lag phase was present in 30% of the patients. PYY levels were significantly higher in BPD-DS patients as compared to controls both in the fasting state (p < 0.001) and after the test meal (p < 0.001). Dumping symptoms were scarce and occurred in 17 of the 20 patients only few times yearly or less.

Conclusions

Although the pylorus is preserved in BPD-DS, the stomach emptying is faster than in non-operated subjects. PYY levels are elevated in the fasting state after BPD-DS and a marked response to a test meal is seen, likely due to the rapid stimulation of intraluminal nutrients in the distal ileum. In spite of this, dumping symptoms are uncommon.
Literature
1.
go back to reference Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.PubMedCrossRef Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.PubMedCrossRef
2.
go back to reference Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102.PubMedCrossRef Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102.PubMedCrossRef
3.
go back to reference Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138–45.PubMedCrossRef Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138–45.PubMedCrossRef
4.
go back to reference Duval K, Marceau P, Lescelleur O, et al. Health-related quality of life in morbid obesity. Obes Surg. 2006;16:574–9.PubMedCrossRef Duval K, Marceau P, Lescelleur O, et al. Health-related quality of life in morbid obesity. Obes Surg. 2006;16:574–9.PubMedCrossRef
5.
go back to reference Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.PubMedCrossRef Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.PubMedCrossRef
6.
go back to reference Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–6.PubMedCrossRef Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–6.PubMedCrossRef
7.
go back to reference Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–9.PubMedCrossRef Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–9.PubMedCrossRef
8.
9.
go back to reference Freedman DM, Ron E, Ballard-Barbash R, et al. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond). 2006;30:822–9.CrossRef Freedman DM, Ron E, Ballard-Barbash R, et al. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond). 2006;30:822–9.CrossRef
10.
go back to reference Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev 2005:CD003641 Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev 2005:CD003641
11.
go back to reference Sundbom M, Karlson BM. Low mortality in bariatric surgery 1995 through 2005 in Sweden, in spite of a shift to more complex procedures. Obes Surg. 2009;19:1697–701.PubMedCrossRef Sundbom M, Karlson BM. Low mortality in bariatric surgery 1995 through 2005 in Sweden, in spite of a shift to more complex procedures. Obes Surg. 2009;19:1697–701.PubMedCrossRef
12.
go back to reference MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg. 2000;231:524–8.PubMedCrossRef MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg. 2000;231:524–8.PubMedCrossRef
13.
14.
go back to reference Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.PubMedCrossRef Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–54.PubMedCrossRef
15.
go back to reference Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15:408–16.PubMedCrossRef Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15:408–16.PubMedCrossRef
16.
go back to reference Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66:618–20.PubMedCrossRef Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66:618–20.PubMedCrossRef
17.
go back to reference Latarjet A. Section des rameaux gastriques du vague. Presse Méd. 1921;41:409. Latarjet A. Section des rameaux gastriques du vague. Presse Méd. 1921;41:409.
18.
go back to reference McCrea ED. The abdominal distribution of the vagus. J Anat. 1924;59:18–40.PubMed McCrea ED. The abdominal distribution of the vagus. J Anat. 1924;59:18–40.PubMed
19.
go back to reference Holzer HH, Raybould HE. Vagal and splanchnic sensory pathways mediate inhibition of gastric motility induced by duodenal distension. Am J Physiol. 1992;262:G603–8.PubMed Holzer HH, Raybould HE. Vagal and splanchnic sensory pathways mediate inhibition of gastric motility induced by duodenal distension. Am J Physiol. 1992;262:G603–8.PubMed
20.
go back to reference Yung BC, Sostre S. Lag phase in solid gastric emptying: comparison of quantification by physiological and mathematical definitions. J Nucl Med. 1993;34:1701–5.PubMed Yung BC, Sostre S. Lag phase in solid gastric emptying: comparison of quantification by physiological and mathematical definitions. J Nucl Med. 1993;34:1701–5.PubMed
21.
go back to reference Collins PJ, Horowitz M, Cook DJ, et al. Gastric emptying in normal subjects—a reproducible technique using a single scintillation camera and computer system. Gut. 1983;24:1117–25.PubMedCrossRef Collins PJ, Horowitz M, Cook DJ, et al. Gastric emptying in normal subjects—a reproducible technique using a single scintillation camera and computer system. Gut. 1983;24:1117–25.PubMedCrossRef
22.
go back to reference Vazquez Roque MI, Camilleri M, Stephens DA, et al. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006;131:1717–24.PubMedCrossRef Vazquez Roque MI, Camilleri M, Stephens DA, et al. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006;131:1717–24.PubMedCrossRef
23.
go back to reference Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19:1515–21.PubMedCrossRef Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19:1515–21.PubMedCrossRef
24.
go back to reference Bernstine H, Tzioni-Yehoshua R, Groshar D, et al. Gastric emptying is not affected by sleeve gastrectomy—scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg. 2009;19:293–8.PubMedCrossRef Bernstine H, Tzioni-Yehoshua R, Groshar D, et al. Gastric emptying is not affected by sleeve gastrectomy—scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg. 2009;19:293–8.PubMedCrossRef
25.
go back to reference Michiura T, Nakane Y, Kanbara T, et al. Assessment of the preserved function of the remnant stomach in pylorus-preserving gastrectomy by gastric emptying scintigraphy. World J Surg. 2006;30:1277–83.PubMedCrossRef Michiura T, Nakane Y, Kanbara T, et al. Assessment of the preserved function of the remnant stomach in pylorus-preserving gastrectomy by gastric emptying scintigraphy. World J Surg. 2006;30:1277–83.PubMedCrossRef
26.
go back to reference Nishikawa K, Kawahara H, Yumiba T, et al. Functional characteristics of the pylorus in patients undergoing pylorus—preserving gastrectomy for early gastric cancer. Surgery. 2002;131:613–24.PubMedCrossRef Nishikawa K, Kawahara H, Yumiba T, et al. Functional characteristics of the pylorus in patients undergoing pylorus—preserving gastrectomy for early gastric cancer. Surgery. 2002;131:613–24.PubMedCrossRef
27.
go back to reference Lundberg JM, Tatemoto K, Terenius L, et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA. 1982;79:4471–5.PubMedCrossRef Lundberg JM, Tatemoto K, Terenius L, et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA. 1982;79:4471–5.PubMedCrossRef
28.
go back to reference Savage AP, Adrian TE, Carolan G, et al. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 1987;28:166–70.PubMedCrossRef Savage AP, Adrian TE, Carolan G, et al. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 1987;28:166–70.PubMedCrossRef
29.
go back to reference Imamura M. Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides. 2002;23:403–7.PubMedCrossRef Imamura M. Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides. 2002;23:403–7.PubMedCrossRef
30.
go back to reference Van Citters GW, Lin HC. The ileal brake: a 15-year progress report. Curr Gastroenterol Rep. 1999;1:404–9.PubMedCrossRef Van Citters GW, Lin HC. The ileal brake: a 15-year progress report. Curr Gastroenterol Rep. 1999;1:404–9.PubMedCrossRef
31.
go back to reference Adrian TE, Long RG, Fuessl HS, et al. Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci. 1985;30:1145–8.PubMedCrossRef Adrian TE, Long RG, Fuessl HS, et al. Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci. 1985;30:1145–8.PubMedCrossRef
32.
go back to reference Allen JM, Fitzpatrick ML, Yeats JC, et al. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion. 1984;30:255–62.PubMedCrossRef Allen JM, Fitzpatrick ML, Yeats JC, et al. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion. 1984;30:255–62.PubMedCrossRef
33.
34.
go back to reference Holdstock C, Zethelius B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond). 2008;32:1640–6.CrossRef Holdstock C, Zethelius B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond). 2008;32:1640–6.CrossRef
35.
go back to reference Gryback P, Hermansson G, Lyrenas E, et al. Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trial. Eur J Nucl Med. 2000;27:647–55.PubMedCrossRef Gryback P, Hermansson G, Lyrenas E, et al. Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trial. Eur J Nucl Med. 2000;27:647–55.PubMedCrossRef
36.
go back to reference Gryback P, Bajc M, Granerus G, et al. [Examination of gastric emptying with gamma camera. Clinically useful, uniform method now established]. Lakartidningen. 2000;97:1811–6.PubMed Gryback P, Bajc M, Granerus G, et al. [Examination of gastric emptying with gamma camera. Clinically useful, uniform method now established]. Lakartidningen. 2000;97:1811–6.PubMed
37.
go back to reference Sanchez-Pernaute A, Rodriguez R, Rubio MA, et al. Gastric tube volume after duodenal switch and its correlation to short-term weight loss. Obes Surg. 2007;17:1178–82.PubMedCrossRef Sanchez-Pernaute A, Rodriguez R, Rubio MA, et al. Gastric tube volume after duodenal switch and its correlation to short-term weight loss. Obes Surg. 2007;17:1178–82.PubMedCrossRef
38.
go back to reference Moore JG, Christian PE, Coleman RE. Gastric emptying of varying meal weight and composition in man. Evaluation by dual liquid- and solid-phase isotopic method. Dig Dis Sci. 1981;26:16–22.PubMedCrossRef Moore JG, Christian PE, Coleman RE. Gastric emptying of varying meal weight and composition in man. Evaluation by dual liquid- and solid-phase isotopic method. Dig Dis Sci. 1981;26:16–22.PubMedCrossRef
39.
go back to reference Naslund E, Gryback P, Hellstrom PM, et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord. 1997;21:387–92.PubMedCrossRef Naslund E, Gryback P, Hellstrom PM, et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord. 1997;21:387–92.PubMedCrossRef
40.
go back to reference Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349:941–8.PubMedCrossRef Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349:941–8.PubMedCrossRef
41.
go back to reference Stock S, Leichner P, Wong AC, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab. 2005;90:2161–8.PubMedCrossRef Stock S, Leichner P, Wong AC, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab. 2005;90:2161–8.PubMedCrossRef
42.
go back to reference Kim BJ, Carlson OD, Jang HJ, et al. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab. 2005;90:6665–71.PubMedCrossRef Kim BJ, Carlson OD, Jang HJ, et al. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab. 2005;90:6665–71.PubMedCrossRef
43.
go back to reference Boggiano MM, Chandler PC, Oswald KD, et al. PYY3-36 as an anti-obesity drug target. Obes Rev. 2005;6:307–22.PubMedCrossRef Boggiano MM, Chandler PC, Oswald KD, et al. PYY3-36 as an anti-obesity drug target. Obes Rev. 2005;6:307–22.PubMedCrossRef
44.
go back to reference Johansson HE, Haenni A, Karlsson FA, et al. Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obes Surg. 2010;20:549–58.PubMedCrossRef Johansson HE, Haenni A, Karlsson FA, et al. Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obes Surg. 2010;20:549–58.PubMedCrossRef
Metadata
Title
Gastric Emptying and Postprandial PYY Response After Biliopancreatic Diversion with Duodenal Switch
Authors
Jakob Hedberg
Hans Hedenström
F. Anders Karlsson
Britt Edén-Engström
Magnus Sundbom
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 5/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0288-7

Other articles of this Issue 5/2011

Obesity Surgery 5/2011 Go to the issue